Dow Up0.25% Nasdaq Up0.65%

Amyris, Inc. (AMRS)

-NasdaqGS
0.59 Up 0.03(5.18%) May 27, 4:00PM EDT
ProfileGet Profile for:
Amyris, Inc.
5885 Hollis Street
Suite 100
Emeryville, CA 94608
United States - Map
Phone: 510-450-0761
Fax: 510-225-2645
Website: http://www.amyris.com

Details 
Index Membership:N/A
Sector:Basic Materials
Industry:Specialty Chemicals
Full Time Employees:403

Business Summary 

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Amyris, Inc.

Corporate Governance 
Amyris, Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. John G. Melo , 50
Chief Exec. Officer, Pres and Director
822.00K0.00
Mr. Raffi Mark Asadorian , 47
Chief Financial Officer
567.00K0.00
Mr. Nicholas S. Khadder , 42
Sr. VP, Gen. Counsel and Corp. Sec.
361.00K0.00
Dr. Joel R. Cherry Ph.D., 55
Pres of R&D
439.00K0.00
Ms. Karen Weaver , 55
Principal Accounting Officer, VP of Fin. and Corp. Controller
N/AN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders